Abstract
INTRODUCTION
The Health Equity Scholars Program (HESP) addresses the critical need for a diverse, culturally competent workforce to study and treat older adults from underrepresented populations (URPs) with Alzheimer’s disease and related dementias (AD/ADRD). The HESP offers tailored mentored training in AD/ADRD research concepts, aiming to develop successful independent researchers. It recruits Scholars from underrepresented backgrounds as well as those passionate about AD/ADRD health equity research.
METHODS
We (1) describe the fundamental elements of the HESP, and (2) present preliminary data from the HESP program evaluation results performed by an outside agency, pre–post participation surveys, and Scholar accomplishments.
RESULTS
The HESP Scholars reported high rates of proficiency, satisfaction, and competency in nearly all evaluated areas, and have been successful in obtaining grants, promotions, and publications.
DISCUSSION
These initial outcomes data suggest that the HESP is meeting its objective of diversifying the workforce in the field of AD/ADRD research and care.
Highlights
The Health Equity Scholars Program aims to cultivate a diverse and culturally competent workforce, who are well-prepared to study and treat underrepresented older adults with Alzheimer’s disease and related dementias (AD/ADRD).
The program provides tailored mentored training in AD/ADRD research concepts, with the goal of nurturing successful independent researchers.
Rigorous evaluation processes for applications ensure the selection of highly qualified Scholars.
The program includes tailored training activities such as seminars and grant writing workshops, and tracks Scholar achievements while undergoing annual external evaluation to enhance its training program iteratively.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Hannatu Amaza,
Amber Niay,
Mai Seng Thao,
Joe Strong,
Alyssa Arentoft,
Vanessa Guzman,
Sid E. O’Bryant,
Mike Weiner,
Mónica Rivera Mindt,
Ozioma C. Okonkwo,
for the Alzheimer’s Disease Neuroimaging Initiative,
the HABS‐HD Investigative Team | November 8, 2024